clinical trial for retatrutide eli lilly phase 3 A new trial from Eli Lilly and Company suggests Perceived benefits of treatment for

In order to better understand GLP-1s efficacy for women in midlife, they conducted a secondary analysis of data from the SURMOUNT clinical trial to determine the efficacy of tirzepatide in women in the premenopausal, perimenopausal and postmenopausal stages of life

doi:10.1073/pnas.1000645107 168

For individuals vulnerable to disordered eating, that combination can be combustible

Three large randomized controlled clinical studies, 1 in people with diabetes alone and 2 in people with or without diabetes, tested whether SGLT2is retained their cardiorenal benefits in people with proteinuria, including many with lower levels of eGFR

Regrettably, this GWAS statistic failed to identify the genetic proxies for GIPR and GCGR, thereby impeding the investigation of the potential impacts of multi-target agonists of GLP-1R on liver fibrosis in MASLD